MedPath

Effect of nano-Zataria multiflora supplement on cutaneous candidiasis

Phase 2
Conditions
Cutaneous candidiasis.
Candidiasis of skin and nail
B37.2
Registration Number
IRCT20210611051539N1
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
40
Inclusion Criteria

All patients presenting with mild-moderate cutaneous candidiasis and do not require treatment with systemic antifungals.

Exclusion Criteria

Taking antifungal drugs
Children and infants in the age range of 0-10 years

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement of fungal lesions in terms of mycological criteria. Timepoint: Before the intervention, 2 and 4 weeks after the intervention. Method of measurement: Evaluation of clinical symptoms such as erythema, inflammation and pruritus and evaluation of negative direct examination and mycology culture.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath